CRISM Therapeutics Corporation
AMMCF
$6.77
$6.573,309.57%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.87% | 25.87% | 37.87% | 37.87% | -47.87% |
| Total Receivables | -- | -- | 1,202.78% | 1,202.78% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 538.10% | 538.10% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 3.06% |
| Total Current Assets | -83.35% | -83.35% | -79.72% | -79.72% | -7.99% |
|
|
|||||
| Total Current Assets | -83.35% | -83.35% | -79.72% | -79.72% | -7.99% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -83.35% | -83.35% | -79.72% | -79.72% | -7.99% |
|
|
|||||
| Total Accounts Payable | 259.54% | 259.54% | 97.38% | 97.38% | -86.47% |
| Total Accrued Expenses | -86.64% | -86.64% | 66.86% | 66.86% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -38.07% | -38.07% | 196.43% | 196.43% | 10.69% |
| Total Other Current Liabilities | -38.07% | -38.07% | 196.43% | 196.43% | 10.69% |
| Total Current Liabilities | -28.12% | -28.12% | 134.08% | 134.08% | -18.28% |
|
|
|||||
| Total Current Liabilities | -28.12% | -28.12% | 134.08% | 134.08% | -18.28% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -28.12% | -28.12% | 133.41% | 133.41% | -18.28% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.41% |
| Retained Earnings | -99.73% | -99.73% | -105.33% | -105.33% | -8.03% |
| Treasury Stock & Other | -- | -- | 105.97% | 105.97% | 2.20% |
| Total Common Equity | -85.18% | -85.18% | -87.71% | -87.71% | -7.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -85.18% | -85.18% | -87.71% | -87.71% | -7.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -85.18% | -85.18% | -87.71% | -87.71% | -7.61% |
|
|
|||||
